Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

18.57 -0.58 (-3.03%)
Streaming Delayed Price Updated: 9:33 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Looking Into 10x Genomics's Recent Short Interest ↗
 
Via Benzinga
News headline image
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Where 10x Genomics Stands With Analysts ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
In-Depth Examination Of 11 Analyst Recommendations For 10x Genomics ↗
 
Via Benzinga
News headline image
Navigating 11 Analyst Ratings For 10x Genomics ↗
 
Via Benzinga
News headline image
12 Analysts Assess 10x Genomics: What You Need To Know ↗
 
Via Benzinga
News headline image
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings ↗
 
Via Benzinga
News headline image
Dow Falls Over 100 Points; US Inflation Rate Slows To 2.4% In September ↗
 
Via Benzinga
Topics Economy Stocks
News headline image
10x Genomics Crashes After 'Disruptive' Reorg Upsets Third-Quarter Sales ↗
The company is undergoing a reorganization that has proven more "disruptive" than previously expected. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead ↗
10x Genomics reported Q3 2024 revenue of $151.7 million, down 1% from last year. Instruments revenue dropped 46%, while consumables grew 10%. CEO Serge Saxonov acknowledged the challenges faced but... 
Via Benzinga
News headline image
Nasdaq, S&P 500 Futures Slip As September CPI Data Looms, Tesla On Radar Ahead Of Robotaxi Event: Strategist Offers Stock Tips Aligned With Presidential Candidates' Trade Policies ↗
The imminent release of the September consumer price inflation report is keeping sentiment guarded as the index futures trade modestly lower early Thursday. 
Via Benzinga
Topics Economy Stocks
News headline image
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Delta Air Lines, Domino's Pizza And 3 Stocks To Watch Heading Into Thursday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Gold Rally Loses Steam As Treasury Yields Stabilize, Dollar Rebounds: 6 Miner Stocks See Declines On Wednesday ↗
Gold rally loses momentum as dollar rebounds and Treasury yields stabilize. Gold mining stocks also decline due to dip in gold prices. 
Via Benzinga
News headline image
Cisco Posts Upbeat Earnings, Joins Tesla, Ulta Beauty, Robinhood, Dell And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Starbucks To Rally Around 43%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
TXG Stock Earnings: 10x Genomics Beats EPS, Beats Revenue for Q2 2024 ↗
TXG stock results show that 10x Genomics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast ↗
 
Via Benzinga
News headline image
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. 
Via MarketBeat
News headline image
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates ↗
In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fund, ARK Innovation ETF, despite its recent underperformance. 
Via Benzinga
Topics ETFs
News headline image
What's Going On With 10x Genomics Stock On Wednesday? ↗
Illumina acquires Fluent BioSciences to enhance single-cell analysis and multiomics research. 10x Genomics faces challenges as shares drop amid competitive pricing pressures in the single-cell market. 
Via Benzinga
News headline image
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq, S&P 500 Futures Rise Amid Tech Buoyancy, Bitcoin Gains 2%: Analyst Warns Of Elevated Valuations And Potential Election Volatility ↗
The market’s bullish bias will likely be put to the test on Wednesday as some key market-moving catalysts due this week could pose a threat to the upward momentum. 
Via Benzinga
Topics Stocks
News headline image
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.